Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
1 other identifier
observational
2,427
1 country
1
Brief Summary
The goal of this observational study is to assess the utilization of mechanical thrombectomy and catheter-directed thrombolysis in patients with deep vein thrombosis in tertiary care. The main questions it aims to answer are:
- 1.How many patients with deep vein thrombosis are potentially eligible for mechanical thrombectomy and catheter-directed thrombolysis in a tertiary hospital?
- 2.What is the actual number of patients undergoing endovascular interventions for deep vein thrombosis?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 12, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedJune 21, 2024
June 1, 2024
2 years
June 12, 2024
June 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with deep vein thrombosis who could be eligible for mechanical thrombectomy and catheter-directed thrombolysis
The number of participants with deep vein thrombosis who would fit the eligibility criteria for performing the intervention
from date of admission until the date of discharge, up to 1-2 weeks
Secondary Outcomes (1)
The number of patients with deep vein thrombosis who underwent mechanical thrombectomy and catheter-directed thrombolysis
from date of admission until the date of discharge, up to 1-2 weeks
Eligibility Criteria
Patients with deep vein thrombosis referred to the hospital from January 2022 to December 2023.
You may qualify if:
- lower limb, pelvic, or inferior vena cava deep vein thrombosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation
Moscow, 117997, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery, Pirogov RNRMU, Zolotukhin Igor Anatolievich
Study Record Dates
First Submitted
June 12, 2024
First Posted
June 21, 2024
Study Start
January 1, 2022
Primary Completion
December 31, 2023
Study Completion
June 1, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06